The 20% n-Butyllithium Solution (Cyclohexane Solvent) segmentation by application reveals five primary demand drivers. Polymer synthesis accounts for the largest share, roughly 35%, as the reagent is essential for initiating anionic polymerizations of butadiene, styrene, and other monomers, delivering precise molecular weight control. Pharmaceutical intermediates represent about 25% of the market, where the solution is employed to deprotonate heterocycles and generate organolithium intermediates for active pharmaceutical ingredient (API) routes. Agrochemical synthesis contributes 20%, supporting the production of herbicide and insecticide precursors that require strong, non‑nucleophilic bases. Specialty chemicals, at 12%, encompass high‑performance surfactants, dyes, and advanced materials that rely on n‑butyllithium for functional group transformations. Finally, the electronics sector occupies the remaining 8%, primarily for the fabrication of semiconductor materials and lithium‑based battery components where the reagent’s reactivity enables thin‑film deposition and surface modification. These application categories collectively define the market size and guide strategic allocation of R&D and production capacity.